A virtual talk by Dr John Liddell, chief technologist at CPI
Technological advances made in basic molecular biology, manufacturing and formulation technology have made mRNA a highly viable vaccine technology which has been validated with successful mRNA COVID-19 vaccines being administered to 100's of millions of people. This presentation by Dr John Liddell, chief technologist at CPI, will focus on the challenges associated with manufacturing mRNA vaccines with focus on different mRNA formats including self-amplifying RNA.
Cost and booking
This event is free to attend and open to all. Advance registration is essential through the link at the top of the page.
For booking or website queries, please contact Harriet McAra at email@example.com
or on 020 3925 3445.